DrugPatentWatch Database Preview
Details for Patent: 9,168,238
» See Plans and Pricing
Which drugs does patent 9,168,238 protect, and when does it expire?
Patent 9,168,238 protects LEVOTHYROXINE SODIUM and is included in one NDA.
This patent has two patent family members in two countries.
Summary for Patent: 9,168,238
| Title: | Levothyroxine formulations |
| Abstract: | A levothyroxine composition includes levothyroxine sodium and mannitol. The composition is a lyophilized solid. The composition may include from 100 to 500 micrograms levothyroxine sodium and from 2 to 4 milligrams mannitol. |
| Inventor(s): | Jiang; John Zhiqiang (Skokie, IL), Usayapant; Arunya (Mundelein, IL), Monen; George (Woodridge, IL) |
| Assignee: | Fresenius Kabi USA, LLC (Lake Zurich, IL) |
| Application Number: | 14/641,426 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,168,238 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Use; |
Drugs Protected by US Patent 9,168,238
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-001 | Jun 24, 2011 | AP | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-002 | Jun 24, 2011 | AP | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Fresenius Kabi Usa | LEVOTHYROXINE SODIUM | levothyroxine sodium | POWDER;INTRAVENOUS | 202231-003 | Jun 24, 2011 | AP | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,168,238
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2750664 | Start Trial | |||
| World Intellectual Property Organization (WIPO) | 2013033194 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
